Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis
Clinical trial NCT03987620 · COMPLETED
Trial details
- NCT number
- NCT03987620
- Sponsor
- Scynexis, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-07
- Primary completion
- 2020-03-29
- Enrollment
- 455
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.